Product Specification
Species |
Human |
Synonyms |
TNFα;Tumor Necrosis Factor, Cachectin, TNF-Alpha, Tumor Necrosis Factor Ligand Superfamily Member 2, TNF-a, TNF, TNFA, TNFSF2 |
Accession |
P01375 |
Amino Acid Sequence |
Val77-Leu233 |
Expression System |
CHO |
Molecular Weight |
17 kDa(Reducing) |
Purity |
>95%, by SDS-PAGE under reducing conditions |
Endotoxin |
<0.1EU/μg |
Conjugation |
Unconjugated |
Tag |
No Tag |
Physical Appearance |
Lyophilized Powder |
Storage Buffer |
PBS, pH7.4 |
Reconstitution |
Reconstitute at less than 1 mg/mL according to the size in ultrapure water after rapid centrifugation . |
Stability & Storage |
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
|
Background
Tumor necrosis factor alpha (TNFa) is a multifunctional proinflammatory cytokine synthesized mainly by nucleated blood
cells as a 233 aa type II transmembrane protein which is cleaved by ADAM17 between aa 76-77 to form a soluble
homotrimeric complex. TNFa plays a role in lipid metabolism, coagulation, and endothelial function and has been
associated with cancer, infection and inflammation (including inflammatory bowel disease), ischemia/reperfusion injury
and heart failure, and insulin resistance.